Prm1 - Validation of Alternative “Surrogate” Clinical Endpoints in Advanced Melanoma
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2126
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV